NextCure, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 62.72 million compared to USD 74.73 million a year ago. Basic loss per share from continuing operations was USD 2.25 compared to USD 2.69 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | -3.05% |
|
-1.85% | +39.47% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.47% | 4.45Cr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+16.94% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.81% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr |
- Stock Market
- Equities
- NXTC Stock
- News NextCure, Inc.
- NextCure, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023